REPRIEVE (A5332) is a large double-blind, randomized, placebo-controlled study of pitavastatin or placebo for about 72 months....
Study Description A5384 is a trial for people who have or might have tuberculous meningitis (TBM). TBM is an infectious disease...
TB is a major cause of illness and death in women of reproductive age. Pregnant and postpartum women with latent TB are at...
The purpose of this study is to obtain informed consent to use stored human biological materials (HBM) (e.g., blood and other...
An estimated 3 million HIV-infected individuals will enter programs for antiretroviral (ARV) treatment in the coming year, with...
